European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Executive Insights

Life Sciences & Pharma

When Is It Too Late? Drivers of Commercial Performance for Late Entrants in Biopharma

April 28, 2025

Executive Insights

Life Sciences & Pharma

Radiotherapeutics on the Rise: Addressing Supply Chain Complexity

April 7, 2025

Executive Insights

Life Sciences & Pharma

Future Outlook for the AOM Market

January 9, 2025

Video / Webinar

Digital

Driving AI Success: Leadership Strategies from the C-Suite

October 11, 2024

Executive Insights

Life Sciences & Pharma

Understanding the Inflation Reduction Act Negotiation Prices After the Dust Has Settled

September 27, 2024

Executive Insights

Life Sciences & Pharma

Oncology BD&L: Winning in an Increasingly Competitive Environment

September 12, 2024